mcad l carnitine Medium Chain Acyl Coenzyme A Dehydrogenase - an overview Carnitine Palmitoyltransferase 2 (CPT2) Deficiency
Description
It is prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act and is dispensed solely pursuant to a valid patient-specific prescription from a licensed healthcare provider
[33] [26] [116] It is also contraindicated in individuals with advanced arteriosclerosis (hardening of the arteries), glaucoma (increased eye pressure), hyperthyroidism (excessive production of thyroid hormone), or moderate to severe hypertension
197, pp
-- 887 35+
